GlassScriptPhysician profile
Heather Bennett Matheson
NPI 1275858839
$12,729.01
in general payments reported to CMS, 2019-2025
23 companies · $175 in 2025
The $175 reported for 2025 was less than what a typical Colon & Rectal Surgery provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,535 · 2020: $180 · 2021: $4,658 · 2022: $136 · 2023: $1,745 · 2024: $1,301 · 2025: $175.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,756 · Food and Beverage: $1,430 · Gift: $34.34.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,756.31 |
| Food and Beverage | $1,430.08 |
| Gift | $34.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $11,549.03 | 2019-2024 | Da Vinci Surgical System |
| Ethicon US, LLC | $192.53 | 2019-2024 | Monocryl, Dermabond Prineo, Vistaseal |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $178.40 | 2019-2022 | |
| Medtronic, INC. | $161.14 | 2021-2025 | Interstim, Dextile |
| Medtronic USA, INC. | $80.14 | 2020 | |
| Axonics, INC. | $76.51 | 2020-2022 | |
| Astrazeneca Pharmaceuticals LP | $65.60 | 2024-2025 | Tagrisso, Andexxa |
| Vioptix INC | $65.60 | 2021 | |
| Conmed Corporation | $50.00 | 2023 | Airseal |
| Pfizer INC. | $39.23 | 2025 | |
| Shire North American Group INC | $33.22 | 2019 | |
| Corcept Therapeutics | $32.19 | 2025 | Korlym |
| Trevena, INC. | $24.28 | 2021-2022 | |
| Braintree Laboratories, INC. | $23.68 | 2023 | Sutab |
| Innovation Technologies INC | $23.16 | 2025 | Irrisept |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Innocoll Pharmaceuticals Limited | $22.88 | 2021 | |
| Amag Pharmaceuticals, INC. | $22.33 | 2021 | |
| Coloplast Corp | $22.23 | 2022 | |
| Polynovo North America LLC | $14.90 | 2025 | Novosorb Btm |
| Tela Bio, INC. | $13.94 | 2020 | |
| Kci USA, INC. | $13.65 | 2023 | V.A.C. Dermatac, 3m Cavilon, Promogran Prisma |
| Stryker Corporation | $12.39 | 2021 | |
| Baudax Bio INC. | $11.98 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heather Matheson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.